Healthcare Services

Hyperimmune Globulins Market Expected to Record Steady Growth and Approach $2.86 Billion by 2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Hyperimmune Globulins Market Projected To Become By 2030 Based On Its 2026 Valuation?

The hyperimmune globulins market size has demonstrated substantial growth in recent years. It is projected to increase from $2.06 billion in 2025 to $2.21 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.6%. This historical growth can be attributed to factors such as the established use in rabies and tetanus prophylaxis, an increasing incidence of infectious diseases, continued reliance on plasma-derived therapies, implementation of government immunization programs, and the expansion of hospital-based emergency care.

The hyperimmune globulins market is projected to experience substantial expansion over the upcoming years. This market is set to reach $2.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. Factors driving this growth during the forecast period include an increase in organ transplantation procedures, a rise in viral infection outbreaks, the broadening of plasma donation networks, significant strides in purification techniques, and a heightened emphasis on swift immune defense. Key developments expected in the same period involve an escalating need for passive immunization treatments, enhanced application in post-exposure prophylaxis, greater acceptance in transplant and immunocompromised patient care, an enlargement of plasma collection and fractionation capabilities, and a reinforcement of regulatory supervision and quality benchmarks.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16448&type=smp

Which Market Drivers Are Supporting The Expansion Of The Hyperimmune Globulins Market?

The hyperimmune globulin market is anticipated to expand in the future due to the rising occurrence of infectious diseases. These illnesses originate from detrimental agents, like viruses, bacteria, fungi, and parasites, entering the body, with their growing prevalence linked to factors such as antimicrobial resistance, shifts in climate, and population increases. Hyperimmune globulins play a crucial role in treating infectious diseases by delivering concentrated antibodies to establish immediate passive immunity against particular pathogens, thus assisting in preventing or managing conditions like rabies, hepatitis B, or tetanus. For example, a report from the UK Health Security Agency in August 2024 indicated that in 2023, the West Midlands region recorded the highest number of measles cases, with 160 cases (44%), followed by London with 122 cases (33%). Children under the age of 10 made up 63% of all cases, totaling 232 cases. Measles activity escalated significantly towards year-end, with 157 new cases in December, a notable increase from just 45 cases in November. Consequently, the rising prevalence of infectious diseases is fostering the growth of the hyperimmune globulin market.

Hyperimmune Globulins Market Driver: Government-Led Healthcare Research And Development Initiatives A Boost For Hyperimmune Globulins

Government-led initiatives for research and development within the healthcare sector are projected to fuel the expansion of the hyperimmune globulins market moving forward. Such governmental efforts in healthcare R&D are increasing due to the heightened demand for innovative medical solutions and the necessity to tackle emerging health challenges. These initiatives facilitate both the creation and availability of hyperimmune globulins, allowing them to effectively combat specific infectious diseases. For instance, as per the Office for National Statistics in May 2024, total healthcare expenditure in the UK saw a 5.6% increase in nominal terms from 2022 to 2023, which represents a considerable acceleration compared to the 0.9% growth recorded in 2022. Therefore, the growing governmental focus on healthcare research and development initiatives is a key driver for the hyperimmune globulins market.

What Segment Groups Are Identified Within The Hyperimmune Globulins Market?

The hyperimmune globulins market covered in this report is segmented –

1) By Type: Hepatitis B Hyperimmune Globulin, Rabies Hyperimmune Globulin, Tetanus Hyperimmune Globulin, Cytomegalovirus (CMV) Hyperimmune Globulin, Varicella-Zoster Virus (VZV) Hyperimmune Globulin, Respiratory Syncytial Virus (RSV) Hyperimmune Globulin, Other Types

2) By Route Of Administration: Intramuscular, Intravenous

3) By Application: Government Institution, Private Sector, Other Applications

Subsegments:

1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin, Intravenous Hepatitis B Hyperimmune Globulin

2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human), Rabies Immune Globulin (Equine)

3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human), Tetanus Immune Globulin (Equine)

4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation, Cmv Immune Globulin For Neonatal Infection

5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis, Vzv Immune Globulin For Immunocompromised Patients

6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children, Rsv Immune Globulin For Adults With Respiratory Conditions

7) By Other Types: Diphtheria Hyperimmune Globulin, Botulism Hyperimmune Globulin, Other Specialized Hyperimmune Globulins

Which Companies Hold Significant Positions In The Hyperimmune Globulins Market?

Major companies operating in the hyperimmune globulins market are Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.

Read the full hyperimmune globulins market report here:

https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report

How Is The Hyperimmune Globulins Market Distributed Across Key Geographic Regions?

North America was the largest region in the hyperimmune globulins market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hyperimmune Globulins Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16448&type=smp

Browse Through More Reports Similar to the Global Hyperimmune Globulins Market 2026, By The Business Research Company

Immunoglobulins Global Market Report

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Mammalian Polyclonal Immunoglobulin G Igg Antibody Global Market Report

https://www.thebusinessresearchcompany.com/report/mammalian-polyclonal-immunoglobulin-g-igg-antibody-global-market-report

Subcutaneous Immunoglobulin Scig Global Market Report

https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795